Vivos Therapeutics, Inc. (VVOS)
0.2652
-0.01
(-4.19%)
USD |
NASDAQ |
Aug 25, 16:00
0.2599
-0.01
(-2.00%)
Pre-Market: 08:51
Vivos Therapeutics Cash from Operations (Quarterly) : -3.148M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.148M |
| March 31, 2026 | -6.01M |
| December 31, 2025 | -3.812M |
| September 30, 2025 | -4.161M |
| June 30, 2025 | -3.494M |
| March 31, 2025 | -3.796M |
| December 31, 2024 | -2.94M |
| September 30, 2024 | -4.187M |
| June 30, 2024 | -3.048M |
| March 31, 2024 | -2.516M |
| December 31, 2023 | -2.748M |
| September 30, 2023 | -2.80M |
| June 30, 2023 | -2.859M |
| March 31, 2023 | -3.539M |
| Date | Value |
|---|---|
| December 31, 2022 | -3.00M |
| September 30, 2022 | -5.842M |
| June 30, 2022 | -4.663M |
| March 31, 2022 | -6.082M |
| December 31, 2021 | -4.122M |
| September 30, 2021 | -4.058M |
| June 30, 2021 | -3.694M |
| March 31, 2021 | -3.861M |
| December 31, 2020 | -3.618M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -0.4369M |
| December 31, 2019 | -1.574M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Hinge Health, Inc. | 101.41M |
| Exlites Holdings International, Inc. | 0.00 |
| Xcelerate, Inc. | -0.0577M |
| Haemonetics Corp. | 52.32M |
| Pro-Dex, Inc. | 1.633M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.416M |
| Cash from Financing (Quarterly) | 3.228M |
| Free Cash Flow | -19.01M |
| Free Cash Flow Per Share (Quarterly) | -0.2016 |
| Free Cash Flow to Equity (Quarterly) | -3.801M |
| Free Cash Flow to Firm (Quarterly) | -2.464M |
| Free Cash Flow Yield | -545.5% |